[colour emphasis and links are mine]
Dr Margaret Chan, Director-General of the World Health Organization
Address to Sixty-second World Health Assembly meeting in Geneva, Switzerland on 18 May 2009
Mister President, honourable ministers, excellencies, distinguished delegates, Dr Mahler, ladies and gentlemen,
Over
the past three decades, the world has, on average, been growing richer.
People have, on average, been enjoying longer and healthier lives.
But
these encouraging trends hide a brutal reality. Today, differences in
income levels, in opportunities, and in health status, within and
between countries, are greater than at any time in recent history.
Our
world is dangerously out of balance, and most especially so in matters
of health. The current economic downturn will diminish wealth and
health, but the impact will be greatest in the developing world.
Human
society has always been characterized by inequities. History has long
had its robber-barons and its Robin Hoods. The difference today is that
these inequities, especially in access to health care, have become so
deadly.
The world can be grateful
that leaders from 189 countries endorsed the Millennium Declaration and
its Goals as a shared responsibility. These Goals are a profoundly
important way to introduce greater fairness in this world.
Populations
all around the world can be grateful that health officials are
recommitting themselves to primary health care. This is the surest
route to greater equity in access to health care.
Public
health can be grateful for backing from the Commission on Social
Determinants of Health. I agree entirely with the findings. The great
gaps in health outcomes are not random. Much of the blame for the
essentially unfair way our world works rests at the policy level.
Time
and time again, health is a peripheral issue when the policies that
shape this world are set. When health policies clash with prospects for
economic gain, economic interests trump health concerns time and time
again. Time and time again, health bears the brunt of short-sighted,
narrowly focused policies made in other sectors.
Equity
in health matters. It matters in life-and-death ways. The HIV/AIDS
epidemic taught us this, in a most visible and measurable way.
We see just how much equity matters when crises arise.
Ladies and gentlemen,
The world is facing multiple crises, on multiple fronts.
Last
year, our imperfect world delivered, in short order, a fuel crisis, a
food crisis, and a financial crisis. It also delivered compelling
evidence that the impact of climate change has been seriously
underestimated.
These crises come at
a time of radically increased interdependence among nations, their
financial markets, economies, and trade systems. All of these crises
are global, and all will hit developing countries and vulnerable
populations the hardest. All threaten to leave this world even more
dangerously out of balance.
All will
show the consequences of decades of failure to invest in health
systems, decades of failure to consider the importance of equity, and
decades of blind faith that mere economic growth is the be-all,
end-all, cure-for-all.
It is not.
The
consequences of flawed policies show no mercy and make no exceptions on
the basis of fair play. As we have seen, the financial crisis has been
highly contagious, moving rapidly from one country to another, and from
one sector of the economy to many others.
Even
countries that managed their economies well, did not purchase toxic
assets, and did not take excessive financial risks are suffering the
consequences. Likewise, the countries that contributed least to
greenhouse gas emissions will be the first and hardest hit by climate
change.
And now we have another great global contagion on our doorstep: the prospect of the first influenza pandemic of this century.
Ladies and gentlemen,
For
five long years, outbreaks of highly pathogenic H5N1 avian influenza in
poultry, and sporadic frequently fatal cases in humans, have
conditioned the world to expect an influenza pandemic, and a highly
lethal one. As a result of these long years of conditioning, the world
is better prepared, and very scared.
As
we now know, a new influenza virus with great pandemic potential, the
new influenza A (H1N1) strain, has emerged from another source on
another side of the world. Unlike the avian virus, the new H1N1 virus
spreads very easily from person to person, spreads rapidly within a
country once it establishes itself, and is spreading rapidly to new
countries. We expect this pattern to continue.
Unlike
the avian virus, H1N1 presently causes mainly mild illness, with few
deaths, outside the outbreak in Mexico. We hope this pattern continues.
New
diseases are, by definition, poorly understood when they emerge, and
this is most especially true when the causative agent is an influenza
virus.
Influenza viruses are the
ultimate moving target. Their behaviour is notoriously unpredictable.
The behaviour of pandemics is as unpredictable as the viruses that
cause them. No one can say how the present situation will evolve.
The
emergence of the H1N1 virus creates great pressure on governments,
ministries of health, and WHO to make the right decisions and take the
right actions at a time of great scientific uncertainty.
On 29 April, I raised the level of pandemic influenza alert from phase 4 to phase 5. We remain in phase 5 today.
This
virus may have given us a grace period, but we do not know how long
this grace period will last. No one can say whether this is just the
calm before the storm.
Presence of
the virus has now been confirmed in several countries in the southern
hemisphere, where epidemics of seasonal influenza will soon be picking
up. We have every reason to be concerned about interactions of the new
H1N1 virus with other viruses that are currently circulating in humans.
Moreover,
we must never forget that the H5N1 avian influenza virus is now firmly
established in poultry in several countries. No one can say how this
avian virus will behave when pressured by large numbers of people
infected with the new H1N1 virus.
Ladies and gentlemen,
The
move to phase 5 activated a number of stepped up preparedness measures.
Public health services, laboratories, WHO staff, and industry are
working around the clock.
A defining
characteristic of a pandemic is the almost universal vulnerability of
the world’s population to infection. Not all people become infected,
but nearly all people are at risk.
Manufacturing
capacity for antiviral drugs and influenza vaccines is finite and
insufficient for a world with 6.8 billion inhabitants. It is absolutely
essential that countries do not squander these precious resources
through poorly targeted measures.
As
you heard this morning, we are trying to get some answers to a number
of questions that will strengthen risk assessment and allow me to issue
more precise advice to governments. Ideally, we will have sufficient
knowledge soon to advise countries on high-risk groups and recommend
that efforts and resources be targeted to these groups.
I
have listened very carefully to your comments this morning. As the
chief technical officer of this Organization, I will follow your
instructions carefully, particularly concerning criteria for a move to
phase 6, in discharging my duties and responsibilities to Member States.
While
many questions do not have firm answers right now, I can assure you on
one point. When WHO receives information of life-saving importance,
such as the heightened risk of complications in pregnant women, we
alert the international community immediately.
To
date, most outbreaks have occurred in countries with good detection and
reporting capacities. Let me take this opportunity to thank the
governments of these countries for the diligence of their surveillance,
their transparency in reporting, and their generosity in sharing
information and viruses.
An
influenza pandemic is an extreme expression of the need for solidarity
before a shared threat. We are fortunate that the outbreaks are causing
mainly mild cases of illness in these early days.
I
strongly urge the international community to use this grace period
wisely. I strongly urge you to look closely at anything and everything
we can do, collectively, to protect developing countries from, once
again, bearing the brunt of a global contagion.
I
have reached out to the manufacturers of antiviral drugs and vaccines.
I have reached out to Member States, donor countries, UN agencies,
civil society organizations, nongovernmental organizations, and
foundations.
I have stressed to them
the absolute need to extend preparedness and mitigation measures to the
developing world. The United Nations Secretary-General is joining me in
these efforts, which are tireless.
Ladies and gentlemen,
As I said, equity in health matters in life-and-death ways. It matters most especially in times of crisis.
The
world of today is more vulnerable to the adverse effects of an
influenza pandemic than it was in 1968, when the last pandemic of the
previous century began.
The speed
and volume of international travel have increased to an astonishing
degree. As we are seeing right now with H1N1, any city with an
international airport is at risk of an imported case. The radically
increased interdependence of countries amplifies the potential for
economic disruption.
Apart from an
absolute moral imperative, trends such as outsourcing and just-in-time
production compel the international community to make sure that no part
of the world suffers disproportionately. We have to care about equity.
We have to care about fair play.
These
vulnerabilities, to imported cases, to disrupted economies and
businesses, affect all countries. Unfortunately, other vulnerabilities
are overwhelmingly concentrated in the developing world.
On
current evidence, most cases of severe and fatal infections with the
H1N1 virus, outside the outbreak in Mexico, are occurring in people
with underlying chronic conditions. In recent years, the burden of
chronic diseases has increased dramatically, and shifted dramatically,
from rich countries to poorer ones.
Today,
around 85% of the burden of chronic diseases is concentrated in low-
and middle-income countries. The implications are obvious. The
developing world has, by far, the largest pool of people at risk for
severe and fatal H1N1 infections.
A
striking feature of some of the current outbreaks is the presence of
diarrhoea or vomiting in as many as 25% of cases. This is unusual.
If
virus shedding is detected in faecal matter, this would introduce an
additional route of transmission. The significance could be especially
great in areas with inadequate sanitation, including crowded urban
shantytowns.
The next pandemic
will be the first to occur since the emergence of HIV/AIDS and the
resurgence of tuberculosis, also in its drug-resistant forms. Today’s
world has millions of people whose lives depend on a regular supply of
drugs and regular access to health services.
Most
of these people live in countries where health systems are already
overburdened, understaffed, and poorly funded. The financial crisis is
expected to increase that burden further, as more people forego private
care and turn to publicly-financed services.
What
will happen if sudden surges in the number of people requiring care for
influenza push already fragile health services over the brink? What
will happen if the world sees the end of an influenza pandemic, only to
find itself confronted, say, with an epidemic of extensively
drug-resistant tuberculosis?
We have
good reason to believe that pregnant women are at heightened risk of
severe or fatal infections with the new virus. We have to ask the
question. Will spread of the H1N1 virus increase the already totally
unacceptable levels of maternal mortality, which are so closely linked
to weak health systems?
Ladies and gentlemen,
In
the midst of all these uncertainties, one thing is sure. When an
infectious agent causes a global public health emergency, health is not
a peripheral issue. It moves straight to centre stage.
The
world is concerned about the prospect of an influenza pandemic, and
rightly so. This Health Assembly has been shortened for a good reason.
Health officials are now too important to be away from their home
countries for more than a few days.
Much is in our hands. How we manage this situation can be an investment case for public health.
The
world will be watching, and one big question is certain to arise. Are
the world’s public health services fit-for-purpose under the
challenging conditions of this 21st century? Of course not. And I think
the consequences will be quickly, highly, and tragically visible. Now
comes the second question. Will something finally be done?
At
the same time, we cannot, we dare not, let concerns about a pandemic
overshadow or interrupt other vital health programmes. In fact, many of
the issues you will be addressing this week, or have addressed in
recent sessions, concern exactly the capacities that will be needed
during a pandemic, or any other public health emergency of
international concern.
The health sector cannot be blamed for lack of foresight. We have long known what is needed.
An
effective public health response depends on strong health systems that
are inclusive, offering universal coverage right down to the community
level. It depends on adequate numbers of appropriately trained,
motivated, and compensated staff.
It
depends on fair access to affordable medical products and other
interventions. All of these items are on your agenda. I urge you, in
particular, to complete work under the item on public health,
innovation and intellectual property. We are so very close.
The
International Health Regulations, also on your agenda, give the health
sector an advantage that financial managers, at the start of last
year’s crisis, did not have when faulty policies precipitated a global
economic downturn. The International Health Regulations provide a
coordinated mechanism of early alert, and an orderly system for risk
management that is driven by science, and not by vested interests.
I
must remind you. We need to finish the job of polio eradication, as
guided by the ongoing independent evaluation. I must also remind you
that this job is already providing solid benefits as we reach for the
goal of ridding the world of a devastating disease.
Right
now, the vast surveillance networks and infrastructure in place for
polio eradication are being used to step up surveillance for cases of
H1N1 infection, especially in sub-Saharan Africa and the Asian
sub-continent.
The proposed
programme budget is also on your agenda. WHO is prepared to lead the
response to a global public health emergency. Our services, in several
areas, are strained, but we are coping. We need to be assured that we
can continue to function well, especially if the emergency escalates.
Ladies and gentlemen,
I have a final comment to make.
Influenza viruses have the great advantage of surprise on their side. But viruses are not smart. We are.
Preparedness
levels, and the technical and scientific know-how that supports them,
have advanced enormously since 1968. We have the revised International
Health Regulations, and we have tested and robust mechanisms like the
Global Outbreak Alert and Response Network.
As
I said, an influenza pandemic is an extreme expression of the need for
global solidarity. We are all in this together. And we will all get
through this, together.
Thank you.
Comments [0]